Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A broad classification of dysgammaglobulinemias characterized by low or undetectable serum levels of one of the five immunoglobulin classes. Deficiencies of immunoglobulins present variably according to isotype. Selective deficiencies may be caused by decreased or inefficient production from progenitor B cells without any corresponding decreases in the other isotypes. The clinical course and prognosis is dependent upon the severity of the selective deficiency and associated morbidity.
Biomarker and diagnostic research for selective immunoglobulin deficiency disease has been reported in the published literature.
No clinical trials have been registered for selective immunoglobulin deficiency disease.
134 publications have been identified in PubMed for selective immunoglobulin deficiency disease. Research spans Review / Meta-Analysis (23%), Basic Science / Preclinical (23%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 31 | 23% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Laboratory research
31 |
23% |
Disease patterns and progression | 22 | 16% |
Patient case studies | 19 | 14% |
Clinical study results | 15 | 11% |
Testing and diagnosis research | 10 | 7% |
Other research | 5 | 4% |
New treatment approaches | 1 | 1% |
Wang Y (2026). [PMID: 41534718](https://pubmed.ncbi.nlm.nih.gov/41534718/). *J Allergy Clin Immunol*. [Basic Science / Preclinical]
Vatovec T (2026). [PMID: 41540267](https://pubmed.ncbi.nlm.nih.gov/41540267/). *Nat Immunol*. [Basic Science / Preclinical]
Koga T (2026). [PMID: 41620931](https://pubmed.ncbi.nlm.nih.gov/41620931/). *Expert Rev Clin Immunol*. [Review / Meta-Analysis]
Naing A (2026). [PMID: 42103356](https://pubmed.ncbi.nlm.nih.gov/42103356/). *J Immunother Cancer*. [Clinical Trial Publication]
Justiz Vaillant AA (2026). [PMID: 29939682](https://pubmed.ncbi.nlm.nih.gov/29939682/). *Unknown Journal*. [Case Report / Case Series]
Foster M (2026). [PMID: 41902543](https://pubmed.ncbi.nlm.nih.gov/41902543/). *Transfusion*. [Case Report / Case Series]
Bernardino A (2026). [PMID: 42104827](https://pubmed.ncbi.nlm.nih.gov/42104827/). *Acta Med Port*. [Review / Meta-Analysis]
Justiz Vaillant AA (2026). [PMID: 29763203](https://pubmed.ncbi.nlm.nih.gov/29763203/). *Unknown Journal*. [Review / Meta-Analysis]
Yang YH (2026). [PMID: 42093086](https://pubmed.ncbi.nlm.nih.gov/42093086/). *Oncologist*. [Case Report / Case Series]
Tahira A (2026). [PMID: 41700250](https://pubmed.ncbi.nlm.nih.gov/41700250/). *Cureus*. [Case Report / Case Series]